ArticleActa Cardiologica Sinica2026
Joint Expert Consensus on the Sodium Reduction Policy in Taiwan: A Collaborative Declaration by the Taiwan Hypertension Society (THS), Taiwan Society of Cardiology (TSOC), International Life Sciences Institute (ILSI), and Nutrition Society of Taiwan (NST).
Article in Acta Cardiologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Excess sodium intake is a major modifiable risk factor for hypertension and other non-communicable diseases, including stroke, ischemic heart disease, and chronic kidney disease. Globally, average sodium intake remains more than twice the World Health Organization (WHO) recommended limit of 2 g/day, and Taiwan similarly faces a substantial sodium burden, with mean intake exceeding 3 g/day and a persistent policy implementation gap. Given the salt sensitivity of East Asian populations, these excess levels translate into disproportionately higher cardiovascular (CV) and broader health risks. Objective: This consensus provides an evidence-based and culturally tailored roadmap to reduce sodium intake and increase potassium consumption in Taiwan, with the goal of achieving the WHO target of a 30% relative sodium reduction by 2030 and improving national CV health. Methods: The consensus was developed through a comprehensive review of epidemiological studies, randomized trials, meta-analyses, and global burden models on sodium, potassium, and health outcomes. National intake patterns were assessed using Nutrition and Health Survey in Taiwan data from 2017-2020, while disease burden and cost estimates were informed by the Global Burden of Disease 2019 framework and local health statistics. An interdisciplinary expert panel adapted international evidence to the dietary context in Taiwan through iterative deliberation. The Evidence: Robust evidence demonstrates a dose-dependent relationship between sodium intake, blood pressure, and CV risk, with each additional gram of sodium increasing CV disease risk by approximately 6%. Meta-analyses indicate that reducing sodium by 1 g/day lowers systolic blood pressure by about 3 mmHg in hypertensive individuals, and randomized trials such as the Salt Substitute and Stroke Study show that potassium-enriched salt can reduce stroke and major CV events. In Taiwan, sodium is derived mainly from salt, sauces, and processed foods, underscoring the need for both household- and industry-level interventions. Scope of the Recommendation: The consensus recommends limiting sodium intake to < 2.3 g/day for adults and < 1.5 g/day for salt-sensitive or hypertensive individuals, while promoting potassium intake > 3.5 g/day from fruits, vegetables, legumes, or potassium-enriched salts (with caution in those at risk of hyperkalemia). Key policy actions include mandatory front-of-pack sodium labeling, food reformulation, institutional procurement standards, and sustained public education, supported by multi-sectoral collaboration across government, academia, industry, and civil society.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.